Travere Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

Go back to Travere Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
(NASDAQ: TVTX) Delayed: 55.64 +0.53 (0.96%)
Previous Close $55.11    52 Week High
Open $54.43    52 Week Low
Day High $56.00    P/E N/A 
Day Low $54.13    EPS
Volume 561,641